SXTCChina SXT Pharmaceuticals, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · sxtchina.com

4.100USDMkt Cap: 2.19M $P/E: —3d ago

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers Advanced TCMP, …

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap2.19M $

Enterprise Value-25.74M $

Revenue (TTM)1.14M $

Gross Profit248.70K $

Net Income (TTM)-6.21M $

Revenue/Share1.674 USD

Last Price4.100 USD

Fiscal Year EndMar 2026

MR QuarterMar 2026

Employees56

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINVGG2161P1320

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA3.65

EV/Revenue-22.62

P/S1.70

P/B0.00

EPS (TTM)-730.40

EPS (Forward)—

52W Range

3.83064% of range4.250

52W High4.250 USD

52W Low3.830 USD

Profitability

Gross Margin21.85%

Oper. Margin-153.28%

EBITDA Margin0.00%

Profit Margin-545.24%

ROE-20.89%

ROA-17.85%

Growth

Revenue Growth-43.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-4.02M $

CapEx (TTM)1.25M $

FCF Margin-416.16%

FCF Yield-216.33%

Net Debt-27.20M $

Net Debt/EBITDA3.86

Balance Sheet

Debt/Equity0.04

Current Ratio7.93

Quick Ratio7.23

Book Value/Sh2480.58 USD

Cash/Share70.32 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:80

Split DateAug 10, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.533.98K

Float399.31K

Insiders—

Institutions—

Short Interest

Short Ratio0.1d

Short % Float10.80%

Short % Out.10.80%

Shares Short57.67K

Short (prev mo.)562

Technical

SMA 50115.43 (-96.4%)

SMA 2004317.19 (-99.9%)

Beta1.89

S&P 52W Chg21.00%

Avg Vol (30d)2.98M

Avg Vol (10d)3.27M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—